
浏览全部资源
扫码关注微信
400038 重庆,陆军军医大学(第三军医大学)第一附属医院急救部
[ 向强,E-mail:Xqiang163@163.com XIANG Qiang, E-mail: Xqiang163@163.com
收稿:2021-07-03,
修回:2021-11-09,
纸质出版:2022-02-15
移动端阅览
李杨, 赵胤杰, 余海燕, 等. 血浆可溶性尿激酶型纤溶酶原激活物受体对重症急性胰腺炎的预测价值[J]. 陆军军医大学学报, 2022,44(3):241-245.
Yang LI, Yinjie ZHAO, Haiyan YU, et al. Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis[J]. Journal of Army Medical University, 2022, 44(3): 241-245.
李杨, 赵胤杰, 余海燕, 等. 血浆可溶性尿激酶型纤溶酶原激活物受体对重症急性胰腺炎的预测价值[J]. 陆军军医大学学报, 2022,44(3):241-245. DOI: 10.16016/j.2097-0927.202107019.
Yang LI, Yinjie ZHAO, Haiyan YU, et al. Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis[J]. Journal of Army Medical University, 2022, 44(3): 241-245. DOI: 10.16016/j.2097-0927.202107019.
目的
2
探讨可溶性尿激酶型纤溶酶原激活物受体(soluble urokinase-type plasminogen activator receptor,suPAR)对重症急性胰腺炎(acute severe pancreatitis,SAP)的预测价值。
方法
2
采用前瞻性队列研究设计,纳入2021年3月1日至6月1日我科收治的急性胰腺炎患者103例[其中SAP 23例,非重症急性胰腺炎(non severe acute pancreatitis
NSAP)80例
]
,采集患者入院即刻血浆样本。同时,招募同期健康体检者30例作为对照组。采用酶联免疫吸附试验检测所有受试者血浆suPAR水平。收集急性胰腺炎患者的一般临床资料及降钙素原(procalcitonin,PCT)、白介素-6(interleukin-6,IL-6)、C反应蛋白(C-reactive protein,CRP)、D-二聚体、血清钙(calcium,Ca
2+
)水平以及血常规、血生化检查结果,并计算急性生理学与慢性健康状况评分系统Ⅱ(acute physiology and chronic health evaluation
APACHE Ⅱ)评分和Ranson’s评分。记录对照组受试者人口学特征(年龄和性别)。采用Pearson相关分析suPAR与APACHE II评分、Ranson’s评分的相关性;采用多因素Logistic回归分析SAP的独立预测因素;采用受试者工作特征(receiver op
erating characteristic,ROC)曲线下面积(area under the curve,AUC)评估上述各独立预测因素对SAP的预测价值。
结果
2
相较于对照组,NSAP及SAP患者血浆suPAR水平明显升高(
P
<0.05),SAP患者suPAR水平明显高于NSAP患者(
P
<0.05)。急性胰腺炎患者血浆suPAR水平与APACHE Ⅱ评分、Ranson’s评分呈正相关(
R
=0.554、
R
=0.485,
P
<0.05),多因素Logistic回归分析表明suPAR、D-二聚体、Ca
2+
是SAP的独立预测因素,ROC曲线分析显示血浆suPAR对SAP有较好的预测价值(AUC=0.869)。
结论
2
血浆suPAR水平与急性胰腺炎患者病情严重程度相关,对预测SAP具有重要价值。
Objective
2
To explore the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) for severe acute pancreatitis (SAP).
Methods
2
A prospective cohort study was designed to enroll 103 patients with acute pancreatitis who were admitted to our department from March 1 to June 1
2021
including 23 SAP and 80 non-severe acute pancreatitis (NSAP). Another 30 healthy subjects were recruited concurrently as control group. The plasma samples of all subjects were collected on the first day of admission to detect the level of suPAR using ELISA. General clinical data and the levels of procalcitonin (PCT)
interleukin-6 (IL-6)
C-reactive protein (CRP)
D-dimer and serum calcium (Ca
2+
)
as well as the results of blood routine and biochemical examinations of patients were all collected. Acute Physiology and Chronic Health Evaluation (APACHEⅡ) score and Ranson's score were subsequently calculated. For the control subjects
only their demographic characteristics (age and gender) were collected. Statistical analysis was adopted on the above data.
Results
2
The plasma suPAR level was significantly higher in the patients with NSAP and SAP than the control group (
P
<
0.05)
and also notably higher in those of the SAP group than those out of the NSAP patients (
P
<
0.05). Pearson correlation ana
lysis showed that plasma suPAR level was positively correlated with both APACHE Ⅱ score and Ranson's score (
R
=0.554
R
=0.485
P
<
0.05). Multivariate Logistic regression analysis indicated that suPAR
D-dimer and Ca
2+
levels were independent predictors of SAP. ROC curve demonstrated that serum suPAR had a good predictive value for SAP (AUC=0.869).
Conclusion
2
The plasma level of suPAR is closely correlated with the severity of acute pancreatitis
and plays an important role in prediction of SAP.
朱文艺, 杜珊珊, 何佳霖, 等. 不同营养支持途径补充谷氨酰胺对重症急性胰腺炎患者血清蛋白水平的叠加效应[J]. 第三军医大学学报, 2016, 38(3): 284-287. DOI: 10.16016/j.1000-5404.201506031.
ZHU W Y, DU S S, HE J L, et al . Superimposed effect of glutamine supplementation by different pathways on serum albumin in severe acute pancreatitis patients[J ] . J Third Mil Med Univ, 2016, 38(3): 284-287. DOI: 10.16016/j.1000-5404.201506 031.
HUANG Q R, XIONG H Y, YAN P J, et al . The diagnostic and prognostic value of suPAR in patients with sepsis: a systematic review and meta-analysis[J ] . Shock, 2020, 53(4): 416-425. DOI: 10.1097/shk.0000000000001434.
LIU K L, FAN J H, WU J. Prognostic role of circulating soluble uPAR in various cancers: a systematic review and meta-analysis[J]. Clin Lab, 2017, 63(5): 871-880. DOI: 10.7754/clin.lab.2017.170110.
KOCH A, ZIMMERMANN H W, GASSLER N, et al . Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure[J ] . Liver Int, 2014, 34(9): 1330-1339. DOI: 10.1111/liv.12512.
王兴鹏, 李兆申, 袁耀宗, 等. 中国急性胰腺炎诊治指南(2013年, 上海)[J]. 胃肠病学, 2013, 18(7): 428-433. DOI: 10.3969/j.issn.1008-7125.2013.07.010.
WANG X P, LI Z S, YUAN Y Z, et al . Guidelines for diagnosis and treatment of acute pancreatitis in China (2013, Shanghai)[J ] . Chin J Gastroenterol, 2013, 18(7): 428-433. DOI: 10.3969/j.issn.1008-7125.2013.07.010.
BANKS P A, BOLLEN T L, DERVENIS C, et al . Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus[J ] . Gut, 2013, 62(1): 102-111. DOI: 10.1136/gutjnl-2012-302779.
杜奕奇, 陈其奎, 李宏宇, 等. 中国急性胰腺炎诊治指南(2019年, 沈阳)[J]. 临床肝胆病杂志, 2019, 35(12): 2706-2711. DOI: 10.3969/j.issn.1001-5256.2019.12.013.
DU Y Q, CHEN Q K, LI H Y, et al . Chinese guidelines for the management of acute pancreatitis (Shenyang, 2019)[J ] . J Clin Hepatol, 2019, 35(12): 2706-2711. DOI: 10.3969/j.issn.1001-5256.2019.12.013.
周圆圆, 杨丽, 廖忠莉, 等. BISAP与Ranson's评分对急性胰腺炎患者预后评估的比较[J]. 第三军医大学学报, 2012, 34(7): 658-661. DOI: 10.16016/j.1000-5404.2012.07.023.
ZHOU Y Y, YANG L, LIAO Z L, et al . BISAP score vs Ranson's criteria in predicting outcomes of acute pancreatitis[J ] . J Third Mil Med Univ, 2012, 34(7): 658-661. DOI: 10.16016/j.1000-5404.2012.07.023.
徐益萍, 骆方军, 郑军, 等. 重症急性胰腺炎患者血清降钙素原与C-反应蛋白测定的临床价值[J]. 中华医院感染学杂志, 2017, 27(5): 1089-1092. DOI: 10.11816/cn.ni.2016-162738.
XU Y P, LUO F J, ZHENG J, et al . Clinical value of serum procalcitonin and C-reactive protein in diagnosis of patients with severe acute pancreatitis[J ] . Chin J Nosocomiol, 2017, 27(5): 1089-1092. DOI: 10.11816/cn.ni.2016-162738.
孔浩, 丁震, 朱先超, 等. 急性胰腺炎患者血浆D-二聚体变化与病情相关性研究[J]. 中华内科杂志, 2007(12): 1011-1013. DOI: 10.3760/j.issn:0578-1426.2007.12.011.
KONG H, DING Z, ZHU X C, et al . Serum D-dimer changes and prognostic implication in acute pancreatitis[J ] . Chin J Intern Med, 2007(12): 1011-1013. DOI: 10.3760/j.issn:0578-1426.2007.12.011.
THUNØ M, MACHO B, EUGEN-OLSEN J. suPAR: the molecular crystal ball[J]. Dis Markers, 2009, 27(3): 157-172. DOI: 10.3233/dma-2009-0657.
GUSTAFSSON A, LJUNGGREN L, BODELSSON M, et al . The prognostic value of suPAR compared to other inflammatory markers in patients with severe sepsis[J ] . Biomark Insights, 2012, 7: 39-44. DOI: 10.4137/bmi.s9460.
LIU B, LI D, HU X, et al . The predictive value of serum calcium for acute pancreatitis with persistent organ failure[J ] . Am J Emerg Med, 2018, 36(4): 726-727. DOI: 10.1016/j.ajem.2017.08.038.
GUSSEN H, HOHLSTEIN P, BARTNECK M, et al . Neutrophils are a main source of circulating suPAR predicting outcome in critical illness[J ] . J Intensive Care, 2019, 7: 26. DOI: 10.1186/s40560-019-0381-5.
PLIYEV B K, MENSHIKOV M Y. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis[J]. Inflammation, 2010, 33(1): 1-9. DOI: 10.1007/s10753-009-9152-0.
HAHM E, WEI C, FERNANDEZ I, et al . Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease[J ] . Nat Med, 2017, 23(1): 100-106. DOI:10.1038/nm.4242.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621